SC 13G/A: MADRIGAL PHARMACEUTICALS, INC.

AI Summary

SC 13G/A filing by MADRIGAL PHARMACEUTICALS, INC..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.0001 — , Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of

Filing Documents

• madrigal13ga2-11142024.htm (SC 13G/A) — 70KB
• 0001013594-24-000984.txt ( ) — 72KB

(a)

Item 1(a). Name of Issuer: Madrigal Pharmaceuticals, Inc.

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: Four Tower Bridge 200 Barr Harbor Drive, Suite 200 West Conshohocken, PA 19428

(a)

Item 2(a). Name of Persons Filing: Paulson & Co. Inc. (the "Reporting Person")

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: 1133 Avenue of the Americas, New York, NY 10036

(c)

Item 2(c). Citizenship: Delaware corporation

(d)

Item 2(d). Title of Class of Securities: Common stock, $0.0001 par value per share (the "Common Stock")

(e)

Item 2(e). CUSIP Number: 558868105 Item 3. If this statement is filed pursuant to Section 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: /x/ Not Applicable (a) / / Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) / / Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) / / Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) / / Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) / / Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E).* (f) / / Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F). (g) / / Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G).** (h) / / Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) / / Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3). (j) / / Non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J). (k) / / Group, in accordance with Section 240.13d-1(b)(1)(ii)(J). Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the Issuer. (a) Amount beneficially owned: 2,042,000 (b) Percent of class: 9.4% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 2,042,000 (See Note 1) (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 2,042,000 (See Note 1) (iv) Shared power to dispose or to direct the disposition of: 0 The aggregate percentage of Common Stock reported owned by each person named herein is based upon 21,810,407 shares of Common Stock outstanding as of October 28, 2024, which is the total

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its or his knowledge and belief, each of the undersigned certifies that the information with respect to it or him set forth in this statement is true, complete and correct. Dated: November 14, 2024 PAULSON & CO. INC. By: /s/ Stuart L. Merzer Stuart L. Merzer, General Counsel & Chief Compliance Officer

View Full Filing

View this SC 13G/A filing on SEC EDGAR